Skip to content
Recall Observatory FDA recall evidence

Drug product

Buprenorphine Sublingual Tablets, 8 mg, 30 count-bottles, Rx only, Manufactured by: Sun Pharma, NDC 62756-460-83.

D-0869-2023

May 03, 2023

Class II

Product summary

Firm
SUN PHARMACEUTICAL INDUSTRIES INC
Event
Event 92256
Status
Terminated
Classification
Class II
Quantity
12,336 bottles
Official record key
drug-enforcement:D-0869-2023

Official wording

Reason: CGMP Deviations

Code information: Lot #: DND1515A, Exp 08/24

Distribution pattern: Product was distributed to 19 distributors nationwide.

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations